Skip to main content

Refsum Disease Presenting with a Late-Onset Leukodystrophy

  • Case Report
  • Chapter
  • First Online:

Part of the book series: JIMD Reports ((JIMD,volume 19))

Abstract

Adult Refsum disease is an autosomal recessive peroxisomal disorder characterized by phytanic acid storage. Clinical symptoms usually begin in late childhood before the age of 20. Typical clinical presentation includes nyctalopia caused by retinitis pigmentosa, and anosmia. After 10–15 years, deafness, cerebellar ataxia, polyneuropathy, ichthyosis, and cardiac arrhythmia can occur.

We report the case of a very late-onset adult Refsum disease presenting with marked cognitive decline and severe leukoencephalopathy, without peripheral nervous system involvement. Brain MRI showed a leukoencephalopathy involving the periventricular white matter, subcortical area, and the brainstem with relative sparing of juxtacortical U fibers. This was associated with severe cortical and subcortical atrophy with ventricle dilatation. MR spectroscopy showed a marked increase in the choline/NAA ratio. Elevated plasma phytanic acid level was found, whereas plasma levels of pristanic and very long chain fatty acids were normal. The patient is homozygous for a previously undescribed PHYH frameshift mutation. Whether the very unusual phenotype is related to this peculiar mutation remains unclear.

Competing interests: None declared

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Jansen GA, Waterham HR, Wanders RJ (2004) Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum Mutat 23(3):209–218

    Article  CAS  PubMed  Google Scholar 

  • Rüether K, Baldwin E, Casteels M et al (2010) Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy. Surv Ophthalmol 55(6):531–538

    Google Scholar 

  • Van den Brink DM, Brites P, Haasjes J et al (2003) Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet 72(2):471–477

    Article  PubMed Central  PubMed  Google Scholar 

  • Wanders RJ, Komen JC (2007) Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid. Biochem Soc Trans 35(Pt 5):865–869

    Article  CAS  PubMed  Google Scholar 

  • Weinstein R (1999) Phytanic acid storage disease (Refsum’s disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. J Clin Apher 14(4):181–184

    Article  CAS  PubMed  Google Scholar 

  • Wierzbicki AS, Mitchell J, Lambert-Hammill M et al (2000) Identification of genetic heterogeneity in Refsum’s disease. Eur J Hum Genet 8(8):649–651

    Article  CAS  PubMed  Google Scholar 

  • Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB (2002) Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem 80(5):727–735

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Flavie Bompaire .

Editor information

Editors and Affiliations

Additional information

Communicated by: Ertan Mayatepek, MD

Appendices

One Sentence Take-Home Message

A 69-year-old female patient, homozygous for a novel PHYH mutation, presented with an unusual Refsum disease phenotype including progressive dementia, gait apraxia, and memory loss, associated with diffuse leukoencephalopathy.

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Flavie Bompaire, Dr. Véronique Marcaud, Mrs. Emmanuelle Le Trionnaire, Dr. Frédéric Sedel, and Prof. Thierry Levade declare that they have no conflict of interest.

Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from the patient for being included in the study.

Animal Rights

This article does not contain any studies with animal subjects performed by any of the authors.

Details of the Contributions of Individual Authors

Drs. Bompaire, Marcaud, and Sedel took care of the patient and diagnosed adult Refsum disease. Mrs. Le Trionnaire and Prof. Levade performed the genetic analysis and its interpretation. Dr. Bompaire wrote the text under the supervision of Dr. Sedel and Prof. Levade, with the help of Dr. Marcaud.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bompaire, F., Marcaud, V., Trionnaire, E.L., Sedel, F., Levade, T. (2014). Refsum Disease Presenting with a Late-Onset Leukodystrophy. In: Zschocke, J., Baumgartner, M., Morava, E., Patterson, M., Rahman, S., Peters, V. (eds) JIMD Reports, Volume 19. JIMD Reports, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2014_355

Download citation

  • DOI: https://doi.org/10.1007/8904_2014_355

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46189-1

  • Online ISBN: 978-3-662-46190-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics